![Dirk Plaga](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dirk Plaga worked as the Chief Financial Officer at Bayer AG and as the Executive Vice President-Global Finance at Evotec SE.
He also served as the Chief Financial Officer at Vita 34 AG from 2022 to 2024.
Mr. Plaga completed his undergraduate degree at Ruhr-Universität Bochum.
| Companies | Position | End |
|---|---|---|
| FAMICORD AG | Director of Finance/CFO | 01/08/2024 |
| EVOTEC SE | Corporate Officer/Principal | - |
| BAYER AG | Director of Finance/CFO | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Ruhr-Universität Bochum
 Ruhr-Universität Bochum Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vita 34 AG
 Vita 34 AG BiotechnologyHealth Technology Provides umbilical stem cell preservation and cord blood-banking services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
